We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.96B
AUM Growth
+$565M
Cap. Flow
-$238M
Cap. Flow %
-2.66%
Top 10 Hldgs %
14.1%
Holding
748
New
26
Increased
189
Reduced
394
Closed
36

Top Buys

Rank Stock Value
1
STAG icon
STAG Industrial
STAG
+$26.5M
2
CRI icon
Carter's
CRI
+$23.3M
3
HWC icon
Hancock Whitney
HWC
+$19.5M
4
UL icon
Unilever
UL
+$16.7M
5
MTDR icon
Matador Resources
MTDR
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.98%
2 Industrials 16.66%
3 Technology 16.47%
4 Financials 13.37%
5 Consumer Discretionary 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWV icon
376
iShares Russell 3000 ETF
IWV
$20.1B
$3.33M 0.04%
15,093
+11,635
+336% +$2.59M
WY icon
377
Weyerhaeuser
WY
$18.2B
$3.32M 0.04%
107,188
-1,626
-1% -$50.4K
VICR icon
378
Vicor
VICR
$10.5B
$3.19M 0.04%
59,427
+6,277
+12% +$330K
NGVT icon
379
Ingevity
NGVT
$2.51B
$3.19M 0.04%
45,283
+7,086
+19% +$500K
MUR icon
380
Murphy Oil
MUR
$5.43B
$3.18M 0.04%
+73,899
New +$3.33M
PSX icon
381
Phillips 66
PSX
$81.6B
$3.16M 0.04%
30,395
-587
-2% -$60K
IVV icon
382
iShares Core S&P 500 ETF
IVV
$893B
$3.14M 0.04%
8,175
-131
-2% -$50.6K
IWO icon
383
iShares Russell 2000 Growth ETF
IWO
$14.8B
$3.1M 0.03%
14,477
-291
-2% -$63.8K
XBI icon
384
State Street SPDR S&P Biotech ETF
XBI
$9.68B
$3.05M 0.03%
36,781
-243
-0.7% -$19.7K
HOLX
385
DELISTED
Hologic
HOLX
$3.05M 0.03%
40,732
-543
-1% -$38.7K
CHD icon
386
Church & Dwight Co
CHD
$23.8B
$3M 0.03%
37,235
TW icon
387
Tradeweb Markets
TW
$21.6B
$2.99M 0.03%
46,121
-2,750
-6% -$162K
OSPN icon
388
OneSpan
OSPN
$604M
$2.96M 0.03%
264,434
-2,205
-0.8% -$25.3K
INTC icon
389
Intel
INTC
$502B
$2.95M 0.03%
111,582
-4,026
-3% -$112K
ZION icon
390
Zions Bancorporation
ZION
$10.4B
$2.92M 0.03%
59,383
-1,000
-2% -$50K
VXF icon
391
Vanguard Extended Market ETF
VXF
$31.2B
$2.91M 0.03%
21,887
+8
+0% +$1.08K
VOO icon
392
Vanguard S&P 500 ETF
VOO
$1T
$2.9M 0.03%
8,258
-2,655
-24% -$938K
CTLT
393
DELISTED
CATALENT, INC.
CTLT
$2.9M 0.03%
64,322
-604,175
-90% -$32.8M
XLK icon
394
State Street Technology Select Sector SPDR ETF
XLK
$121B
$2.76M 0.03%
44,348
-3,500
-7% -$222K
CI icon
395
Cigna
CI
$72.5B
$2.71M 0.03%
8,166
+57
+0.7% +$18K
BJRI icon
396
BJ's Restaurants
BJRI
$1.44B
$2.7M 0.03%
102,234
-1,683
-2% -$49.2K
BIIB icon
397
Biogen
BIIB
$29.9B
$2.63M 0.03%
9,515
-65
-0.7% -$18.4K
CP icon
398
Canadian Pacific Kansas City
CP
$79B
$2.62M 0.03%
35,188
-1,186
-3% -$89.2K
AVTR icon
399
Avantor
AVTR
$9.1B
$2.59M 0.03%
122,930
-45,977
-27% -$952K
AZO icon
400
AutoZone
AZO
$48.8B
$2.58M 0.03%
1,046

Similar funds

Segall Bryant & Hamill's Q4 2022 Portfolio in Review

As of Q4 2022, Segall Bryant & Hamill held 748 positions worth $8.96B, up 6.7% from $8.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Segall Bryant & Hamill's Q4 2022 filing shows 26 new, 189 increased, 394 reduced and 36 closed positions. Its largest new stake was STAG Industrial: 847,354 shares worth $27.4M. The largest sale was CATALENT, INC., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

  • Segall Bryant & Hamill's largest Q4 2022 buy was STAG Industrial: 847,354 shares worth $27.4M.
  • Segall Bryant & Hamill added most to Hancock Whitney in Q4 2022, an estimated $19.5M increase.
  • Segall Bryant & Hamill's biggest Q4 2022 reduction was CATALENT, INC., cutting an estimated $32.8M.
  • Segall Bryant & Hamill fully exited Avalara, Inc. in Q4 2022, selling an estimated $10.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 14% of its $8.96B portfolio in Q4 2022.
  • Segall Bryant & Hamill opened 26 new positions and closed 36 in Q4 2022.
  • Segall Bryant & Hamill's portfolio value rose 6.7% quarter-over-quarter to $8.96B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2022, filed 14 Feb 2023.